Metastatic Oral Cavity Carcinoma
1 clinical trials · Condition
◉ Watch Metastatic Oral Cavity Carcinoma
| Record | Firm | Date |
|---|---|---|
| Methotrexate, Erlotinib, and Celecoxib for the Treatment of Recurrent/Metastatic Head and Neck Cancer in a Rural Midwest United States Population (NCT06997068) | Mayo Clinic | 2025-07-09 |
Track Metastatic Oral Cavity Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.